ImmunologyThe Journal of Experimental MedicinePeer-reviewed
Interleukin-33 from oligodendrocytes sustains effector differentiation of tissue-resident CD8+ T cells and is a druggable target in CNS autoimmune disease
Nicolas Fonta, Nicolas Pagé, Bogna Klimek…·Doron Merkler
This study identifies IL-33 from oligodendrocytes as a key regulator of self-reactive CD8+ T cell differentiation in CNS autoimmunity and shows its potential as a therapeutic target.
13 citationstop 2%